Etocoxib API

Name	Etocoxib
Chinese name	依托考昔
Cas Number	202409-33-4
Source	India
Qualifications	USDMF/-/-/-/-

Etoricoxib is a non-steroidal anti-inflammatory drug with anti-inflammatory, analgesic and antipyretic effects. It is developed and produced by Merck & Co., and is currently listed in 84 countries and regions, including China. This product is a highly selective cyclooxygenase-2 (COX-2) inhibitor with oral activity. It has the advantages of significant curative effect, rapid onset, half-life, once a day administration, and higher clinical compliance. Compared with celecoxib, on the one hand, coxib has a fast onset of action and can quickly relieve pain; on the other hand, its action time is longer and can achieve the purpose of lasting pain relief. Etocoxib is more effective than traditional non-steroidal anti-inflammatory drugs. It is the only coxib drug that has been proven to be effective in the treatment of acute gouty arthritis. Etoricoxib has been recommended for the treatment of acute gouty arthritis by the Gout Diagnosis and Treatment Guidelines of the American Academy of Rheumatology. The Chinese Guidelines for the Diagnosis and Treatment of Osteoarthritis and the opinions of the orthopedic pain management experts of the Orthopedic Branch of the Chinese Medical Association recommend that patients at risk of gastrointestinal tract use selective COX-2 inhibitors, and can use etoricoxib.

Hot Tags: etocoxib api, China, suppliers, manufacturers, factory, customized, price, pricelist, in stock, Active Pharmaceutical Ingredient, Ulipristal Acetate API, Dimethyl Fumarate API, Adapalene API, Itraconazole Hydrochloride API, Tippyridine Hydrochloride API

• Previous: Dapagliflozin API
• Next: Dantrolene Sodium API